Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
JG

Jonathan Gillespie — 5 Patents

Merck: 2 patents #3,930 of 9,382Top 45%
CICorcept Therapeutics Incorporated: 1 patents #55 of 80Top 70%
N.N.V.Organon: 1 patents #58 of 194Top 30%
Lanark, GB: #6 of 40 inventorsTop 15%
Overall (All Time): #907,971 of 4,157,543Top 25%
5 Patents All Time
Jonathan Gillespie has been granted 5 US patents while listed as an inventor at Merck. The first was granted in 2010 and the most recent in September 2024. Jonathan Gillespie ranks #907,971 of 4,157,543 US inventors in our database (top 21.8%). Patent records list Jonathan Gillespie in Lanark, GB.

Patents per Year

Patents granted per year, 2010 to 2024Bar chart with a peak of 2 patents in 2013.peak 22010: 1 patents20102013: 2 patents20132014: 1 patents20142024: 1 patents2024

Issued Patents All Time

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12098144 Piperazine indazole glucocorticoid receptor antagonists Mark Mills, Andrew William Phillips, Bohdan Waszkowycz, Hazel Hunt, Angus Morrison +2 more 2024-09-24 $19,321,000
8633237 Indane derivatives Kevin James Gillen, Craig Jamieson, John MACLEAN, Elizabeth Margaret Moir, Zoran Rankovic 2014-01-21 $305,920,000
8536214 Indane derivatives as AMPA receptor modulators Craig Jamieson, John Kinaird Fergusen MaClean, Elizabeth Margaret Moir, Zoran Rankovic 2013-09-17
8507521 Heterocyclic derivatives Julia Adam, Steven Laats, John Kinnaird Ferguson MacLean, Duncan Robert McArthur 2013-08-13
7687515 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives Jiaqiang Cai, Zoran Rankovic, Philip Jones, David Jonathan Bennett, IAIN ALEXANDER CUMMING 2010-03-30